GenSight Biologics S.A. GSGTF
0.08 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.45 Day range 0.45
0.08 52-week range 0.45
- YTD
- -57.92%
- 1 year
- -57.92%
- Market cap
- 19.62M
- EPS (ttm)
- -0.09
- YTD return
- -57.92%
- 1-year return
- -57.92%
- Volume
- 756
- Avg volume
- 6
- Open
- 0.48
- Previous close
- 0.08
- Day's range
- 0.45 – 0.45
- 52-week range
- 0.08 – 0.45
2Y -0.2400 (-75.00%)
News
Gensight Biologics and the 15-20 National Hospital Announce NEJM Publication on GS030 Phase 1/2 Trial Results in Late-Stage Retinitis Pigmentosa 
GenSight Biologics Announces a Successful €1.0 Million Fundraising Supported by Existing Shareholders 
GenSight Biologics Reports Cash Position as of September 30, 2026 
GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates 
GenSight Biologics Provides September 2026 Business Updates 
Financial Analysis: Pyxis Oncology (NASDAQ:PYXS) and GenSight Biologics (OTCMKTS:GSGTF) 
GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates 
GenSight Biologics Announces the Results of its Combined General Meeting of May 19, 2026 
GenSight Biologics to Hold its Combined General Meeting on May 19, 2026 
GenSight Biologics Announces Publication on Matching-Adjusted Indirect Comparison of Leber Hereditary Optic Neuropathy Treatments
Your note
Sign in to keep a note on GSGTF — it syncs with the Stock Master app.